SIRTRATUMAB VEDOTIN
UNII E58B6OP5QG

Substance Identification & Data

This profile provides standardized clinical and technical data for Sirtratumab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E58B6OP5QG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1824663-83-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
E58B6OP5QG
CAS Registry Number
1824663-83-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SIRTRATUMAB VEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10467
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sirtratumab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIRTRATUMAB VEDOTIN

Common Names & Synonyms

ANTI-SLITRK6 ADC AGS15E
ANTI-SLITRK6 ANTIBODY-DRUG CONJUGATE AGS15E
SIRTRATUMAB VEDOTIN [INN]
SIRTRATUMAB VEDOTIN [WHO-DD]

Technical Codes

AGS-15E
ASG-15ME